Computational modeling of 4-Phenoxynicotinamide and 4-Phenoxypyrimidine-5-carboxamide derivatives as potent anti-diabetic agent against TGR5 receptor

Computational modeling of 4-Phenoxynicotinamide and 4-Phenoxypyrimidine-5-carboxamide derivatives as potent anti-diabetic agent against TGR5 receptor

Computational study was carried out to develop a Quantitative structure-activity relationship (QSAR) model and molecular docking studies on 4-Phenoxynicotinamide and 4-Phenoxypyrimidine-5-carboxamide derivatives as potent anti-diabetic agent. Chemical structure of these molecules were optimized with...

Full description

Bibliographic Details
Main Authors:	Shola Elijah Adeniji, David Ebuka Arthur, Adedirin Oluwaseye
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	Journal of King Saud University: Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S1018364718302428

Similar Items

Quantitative structure-activity relationship (QSAR) modelling study of some novel carboxamide series as new anti-tubercular agents
by: Mustapha Abdullahi, et al.
Published: (2020-08-01)

Computational study of some cancer drugs as potent inhibitors of GSK3β
by: David Ebuka Arthur, et al.
Published: (2020-11-01)

4-Amino-2-phenoxypyrimidine
by: Nasir Shah Bakhtiar, et al.
Published: (2009-08-01)

IN SILICO STUDY FOR INVESTIGATING AND PREDICTING THE ACTIVITIES OF 1,2,4-TRIAZOLE DERIVATIES AS POTENT ANTI-TUBERCULAR AGENTS
by: SHOLA ELIJAH ADENIJI, et al.
Published: (2018-07-01)

2-Phenoxypyrimidine
by: Nasir Shah Bakhtiar, et al.
Published: (2009-01-01)

Homology modeling and molecular docking simulation of some novel imidazo[1,2-a]pyridine-3-carboxamide (IPA) series as inhibitors of Mycobacterium tuberculosis
by: Mustapha Abdullahi, et al.
Published: (2021-01-01)

A Derived QSAR Model for Predicting Some Compounds as Potent Antagonist against Mycobacterium tuberculosis: A Theoretical Approach
by: Shola Elijah Adeniji, et al.
Published: (2019-01-01)

Theoretical modeling and molecular docking simulation for investigating and evaluating some active compounds as potent anti-tubercular agents against MTB CYP121 receptor
by: Shola Elijah Adeniji, et al.
Published: (2018-12-01)

Computational investigation, virtual docking simulation of 1, 2, 4-Triazole analogues and insillico design of new proposed agents against protein target (3IFZ) binding domain
by: Shola Elijah Adeniji, et al.
Published: (2020-08-01)

In-silico design and ADMET predictions of some new imidazo[1,2-a]pyridine-3-carboxamides (IPAs) as anti-tubercular agents
by: Mustapha Abdullahi, et al.
Published: (2021-12-01)

Novel 2-mercapto imidazole and triazole derivatives as potent TGR5 receptor agonists
by: Sameer Agarwal, et al.
Published: (2019-03-01)

Identification and validation of a potent synthetic TGR5 agonist that improves metabolism, inflammation and atherosclerosis
by: Moullan, Norman
Published: (2015)

In silico study for evaluating the binding mode and interaction of 1, 2, 4-triazole and its derivatives as potent inhibitors against Lipoate protein B (LipB)
by: Shola Elijah Adeniji, et al.
Published: (2020-01-01)

4,5,6-Trichloropyrimidine-2-carboxamide
by: Andreas S. Kalogirou, et al.
Published: (2021-02-01)

The effect of 5'-aminoimidazole-4-carboxamide ribonucleoside (AICAR) and 5'-aminoimidazole-4-carboxamide-ribonucleoside-phosphate (ZMP) on myocardial glucose uptake
by: Webster, Ingrid
Published: (2012)

Quantum modelling and molecular docking evaluation of some selected quinoline derivatives as anti-tubercular agents
by: Shola Elijah Adeniji, et al.
Published: (2020-03-01)

Quantitative structure–activity relationship and molecular docking of 4-Alkoxy-Cinnamic analogues as anti-mycobacterium tuberculosis
by: Shola Elijah Adeniji, et al.
Published: (2020-01-01)

Synthesis and Spectroscopic Study of N-(4-aryl)-5-methylisoxazol-4-carboxamide and N-(4-aryl)-3-methylisoxazol-4-carboxamide
by: Huei-Jia Lai, et al.
Published: (2010)

Reactions of 5-(3-alkyltriazeno)imidazole-4-carboxamide
by: Ta, Hue Thu
Published: (1990)

Cyclic and acyclic modifications of 5-aminoimidazole-4-carboxamide
by: Stone, Robert
Published: (1981)

TGR5 Signaling in Hepatic Metabolic Health
by: Marlena M. Holter, et al.
Published: (2020-08-01)

N-(4-Chloro-2-nitrophenyl)-5-methylisoxazole-4-carboxamide
by: De-Cai Wang, et al.
Published: (2011-12-01)

Anti-tubercular modelling, molecular docking simulation and insight toward computational design of novel compounds as potent antagonist against DNA gyrase receptor
by: Shola Elijah Adeniji, et al.
Published: (2020-09-01)

Binding profile of protein–ligand inhibitor complex and structure based design of new potent compounds via computer-aided virtual screening
by: Gideon Adamu Shallangwa, et al.
Published: (2021-08-01)

5-Acetamido-1H-pyrazole-4-carboxamide monohydrate
by: Lhoussaine El Ghayati, et al.
Published: (2016-06-01)

The Studies of 5-aminoimidazole-4-carboxamide riboside(AICAR) on Insulin
by: Pao-Hsien Lu, et al.
Published: (2004)

Design and synthesis of 3-(4-aminophenyl)-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazole-1-carboxamide/carbothioamide analogues as antitubercular agents
by: Mohamed Jawed Ahsan, et al.
Published: (2015-03-01)

TGR5 expression in normal kidney and renal neoplasms
by: Chaohui Lisa Zhao, et al.
Published: (2018-04-01)

5-Benzoyl-N,4-diphenyl-4,5-dihydro-1H-pyrazole-3-carboxamide
by: Long He
Published: (2009-09-01)

A novel QSAR model for designing, evaluating,and predicting the anti-MES activity of new 1H-pyrazole-5-carboxylic acid derivatives
by: Adedirin Oluwaseye, et al.
Published: (2017-07-01)

Theoretical modeling for predicting the activities of some active compounds as potent inhibitors against Mycobacterium tuberculosis using GFA-MLR approach
by: Shola Elijah Adeniji, et al.
Published: (2020-01-01)

SYNTHESIS AND PRIMARY SCREENING OF ANTI-INFLAMMATORY ACTIVITY OF 1,4,5,6-TETRAHYDROPYRIMIDINE-2-CARBOXAMIDES
by: V. Ya. Horishny, et al.
Published: (2018-06-01)

N-(2-Hydroxyethyl)-5-(4-methoxyphenyl)-4H-pyrazole-3-carboxamide
by: Defeng Wu, et al.
Published: (2012-03-01)

4-{[4-(3,5-Dimethoxybenzamido)phenyl]sulfanyl}-N-methylpyridine-2-carboxamide
by: Ting-Ting Huang, et al.
Published: (2011-04-01)

5-Methyl-N-[2-(trifluoromethyl)phenyl]isoxazole-4-carboxamide
by: Ping Wei, et al.
Published: (2012-05-01)

Simultaneous inhibition of FXR and TGR5 exacerbates atherosclerotic formation
by: Shinobu Miyazaki-Anzai, et al.
Published: (2018-09-01)

Comparative analysis of adsorption and corrosion inhibitive properties of ethanol extract of Dialium Guineense leaves for mild steel in 0.5 M HCl
by: Shola Elijah Adeniji, et al.
Published: (2018-05-01)

(3R,4R,5R)-5-(Acetamidomethyl)-N-benzyl-3,4-dihydroxytetrahydrofuran-3-carboxamide
by: Michela I. Simone, et al.
Published: (2010-11-01)

N-(2,4-Difluorophenyl)-5-methyl-1,2-oxazole-4-carboxamide hemihydrate
by: Jian-Guang Yu, et al.
Published: (2012-08-01)

3-Acetyl-5-methyl-1-(4-methylphenyl)-1H-pyrazole-4-carboxamide
by: Hatem A. Abdel-Aziz, et al.
Published: (2010-11-01)